![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
|
|||||||||
Hanzi Hunter — ultra-fast Hanzi study All 1,152 characters from the aioLingua manual |
| Leukemia |
|
Free Subscription
2 Am J Hematol |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Leukemia is free of charge.
Real World Study on the Best CPX-351 Treatment Duration and Timing for Allogeneic
Stem Cell Transplantation.
Am J Hematol. 2025;100:2293-2304.
PubMed
Abstract available
The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory
B-ALL With High Disease Burden.
Am J Hematol. 2025;100:2209-2219.
PubMed
Abstract available
Melnick AF, Mullin C, Lin K, et al. Cdc73 protects Notch-induced T-cell leukemia
cells from DNA damage and mitochondrial stress. Blood. 2023;142(25):2159-2174.
Blood. 2025;146:2493.
PubMed
The impact of fitness and dose intensity on clinical outcomes with
venetoclax-obinutuzumab in CLL.
Blood. 2025;146:2406-2416.
PubMed
Abstract available
Risk factors and outcomes of asparaginase-associated pancreatitis in pediatric
patients with ALL.
Blood. 2025;146:2417-2427.
PubMed
Abstract available
Investigating the prognostic value of non-coding RNAs in chronic lymphocytic
leukemia: insights from a systematic review and meta-analysis.
BMC Cancer. 2025;25:1739.
PubMed
Abstract available
Development of a screening model for APL using cell population data and deep
learning-extracted WBC scattergram features.
BMC Cancer. 2025;25:1725.
PubMed
Abstract available
Bone marrow-based highly sensitive proteomics profiling reveals valuable
biomarkers for pediatric B-cell acute lymphoblastic leukemia.
Cancer Lett. 2025 Nov 11:218130. doi: 10.1016/j.canlet.2025.218130.
PubMed
Abstract available
Outcome of chemotherapy dose reduction in overweight Japanese children with acute
lymphoblastic leukemia.
Int J Hematol. 2025 Nov 10. doi: 10.1007/s12185-025-04103.
PubMed
Long-term remission of CBFA2T3::GLIS2-positive pediatric acute myeloid leukemia
with myeloid sarcoma following unrelated cord blood transplantation.
Leuk Lymphoma. 2025 Nov 13:1-4. doi: 10.1080/10428194.2025.2584684.
PubMed
Allogeneic hematopoietic stem cell transplantation in adult with acute
lymphoblastic leukemia: evolving indications and modalities in shifting
landscape.
Leuk Lymphoma. 2025 Nov 13:1-13. doi: 10.1080/10428194.2025.2584685.
PubMed
Abstract available
Prognostic value of HFA-ICOS risk assessment for cancer therapy-related
cardiovascular toxicity in adults with acute lymphoblastic leukemia.
Leuk Lymphoma. 2025 Nov 11:1-9. doi: 10.1080/10428194.2025.2583445.
PubMed
Abstract available
Differential impact of graft-versus-host disease on post-transplant outcomes of
chronic myelomonocytic leukemia according to transplant procedures.
Leuk Res. 2025;159:108134.
PubMed
Abstract available
Blinatumomab consolidation in children with high-risk first-relapse B-cell
precursor acute lymphoblastic leukemia: final 5-year follow-up analysis of a
randomized multicenter phase 3 study.
Leukemia. 2025 Nov 13. doi: 10.1038/s41375-025-02800.
PubMed
Correspondence to "Regulation of metabolic adaptation and leukemia progression by
MUSASHI2-DEPTOR-KIF11 axis".
Leukemia. 2025 Nov 12. doi: 10.1038/s41375-025-02812.
PubMed
The splicing factor PTBP1 interacts with RUNX1 and is required for leukemia cell
survival.
Leukemia. 2025 Nov 10. doi: 10.1038/s41375-025-02799.
PubMed
Abstract available
Thank you for your interest in scientific medicine.